Literature DB >> 11693514

Presence of granulocytic ehrlichia in ticks and serological evidence of human infection in La Rioja, Spain.

J A Oteo1, H Gil, M Barral, A Pérez, S Jimenez, J R Blanco, V Martinez de Artola, A García-Pérez, R A Juste.   

Abstract

In order to estimate the risks of human granulocytic ehrlichiosis (HGE) in an endemic area for Lyme disease in the North of Spain (La Rioja), we collected and investigated by PCR specific to the E. phagocytophila group DNA, a total of 6870 Ixodes ricinus ticks. We also used an indirect immunofluorescence (IFI) test to study the presence of antibodies to the HGE agent in 147 human serum samples including patients with Lyme disease (LD), forestry workers, and persons with history of previous tick bite. Fifty serum samples from healthy people resident in urban areas and with no history of tick-bite disorder and without tick exposure were used as controls. Four of 76 adults and 49 of 203 nymphs pools carried E. phagocytophila DNA. This result, and the finding of 1.4% of sera reacting in the IFI test confirms that this tick-borne agent is present in La Rioja, and that humans show evidence of contact with it. HGE should be considered in the differential diagnosis of flu-like syndromes in the study area in the north of Spain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11693514      PMCID: PMC2869756          DOI: 10.1017/s0950268801005878

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  9 in total

Review 1.  Coinfections acquired from ixodes ticks.

Authors:  Stephen J Swanson; David Neitzel; Kurt D Reed; Edward A Belongia
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

2.  High diversity of ankA sequences of Anaplasma phagocytophilum among Ixodes ricinus ticks in Germany.

Authors:  Friederike D von Loewenich; Birgit U Baumgarten; Klaus Schröppel; Walter Geissdörfer; Martin Röllinghoff; Christian Bogdan
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

3.  Serologic evidence of Anaplasma phagocytophilum infections in patients with a history of tick bite in central Slovakia.

Authors:  Elena Kocianová; Zina Kost'anová; Katarína Stefanidesová; Eva Spitalská; Vojtech Boldis; Daniela Hucková; Gerold Stanek
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

4.  Detection of Anaplasma phagocytophilum DNA in Ixodes ticks (Acari: Ixodidae) from Madeira Island and Setubal District, mainland Portugal.

Authors:  Ana Sofia Santos; Maria Margarida Santos-Silva; Victor Carlos Almeida; Fátima Bacellar; John Stephen Dumler
Journal:  Emerg Infect Dis       Date:  2004-09       Impact factor: 6.883

5.  Human Exposure to Anaplasma phagocytophilum in Two Cities of Northwestern Morocco.

Authors:  Sarah Elhamiani Khatat; Hamid Sahibi; Mony Hing; Ismail Alaoui Moustain; Hamid El Amri; Mohammed Benajiba; Malika Kachani; Luc Duchateau; Sylvie Daminet
Journal:  PLoS One       Date:  2016-08-17       Impact factor: 3.240

6.  Serological evaluation of selected vector-borne pathogens in owned dogs from northern Spain based on a multicenter study using a commercial test.

Authors:  David Díaz-Regañón; Xavier Roura; María L Suárez; Marta León; Ángel Sainz
Journal:  Parasit Vectors       Date:  2020-06-10       Impact factor: 3.876

7.  Seropositivity rates for agents of canine vector-borne diseases in Spain: a multicentre study.

Authors:  Guadalupe Miró; Ana Montoya; Xavier Roura; Rosa Gálvez; Angel Sainz
Journal:  Parasit Vectors       Date:  2013-04-22       Impact factor: 3.876

Review 8.  Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and Ehrlichia ewingii ehrlichiosis.

Authors:  Rachael J Thomas; J Stephen Dumler; Jason A Carlyon
Journal:  Expert Rev Anti Infect Ther       Date:  2009-08       Impact factor: 5.854

9.  Assessment of antibodies against surface and outer membrane proteins of Anaplasma phagocytophilum in Lyme borreliosis and tick-borne encephalitis paediatric patients.

Authors:  L Krbková; L Homola; A Hlaváčová; P Mikolášek; J Bednářová; Z Čermáková
Journal:  Epidemiol Infect       Date:  2016-05-16       Impact factor: 4.434

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.